Atossa Genetics Inc (ATOS)vsModerna Inc (MRNA)
ATOS
Atossa Genetics Inc
$2.45
+4.70%
HEALTHCARE · Cap: $20.46M
MRNA
Moderna Inc
$203.21
+6.95%
HEALTHCARE · Cap: $75.86B
Smart Verdict
WallStSmart Research — data-driven comparison
ATOS leads profitability with a 0.0% profit margin vs -141.4%. ATOS earns a higher WallStSmart Score of 27/100 (F).
ATOS
Avoid27
out of 100
Grade: F
MRNA
Avoid21
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ATOS.
Margin of Safety
+69.9%
Fair Value
$134.59
Current Price
$203.21
$68.62 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 12.0x book value
2.1% revenue growth
Weak financial health signals
ROE of -46.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ATOS
The strongest argument for ATOS centers on Price/Book.
Bull Case : MRNA
The strongest argument for MRNA centers on Market Cap, Debt/Equity.
Bear Case : ATOS
The primary concerns for ATOS are Revenue Growth, EPS Growth, Market Cap.
Bear Case : MRNA
The primary concerns for MRNA are Price/Book, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
ATOS profiles as a value stock while MRNA is a turnaround play — different risk/reward profiles.
ATOS carries more volatility with a beta of 1.27 — expect wider price swings.
MRNA is growing revenue faster at 2.1% — sustainability is the question.
ATOS generates stronger free cash flow (-10M), providing more financial flexibility.
Bottom Line
ATOS scores higher overall (27/100 vs 21/100). MRNA offers better value entry with a 69.9% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Atossa Genetics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
Moderna Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?